Johnson & Johnson (TSX:JNJ)

Market Cap	684.28B
Revenue (ttm)	128.48B
Net Income (ttm)	35.02B
Shares Out	n/a
EPS (ttm)	14.43
PE Ratio	19.54
Forward PE	18.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,997
Average Volume	5,494
Open	26.65
Previous Close	26.66
Day's Range	26.45 - 26.65
52-Week Range	18.75 - 27.92
Beta	n/a
RSI	48.14
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD